Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thrombin Generation as a New Test for Anticoagulation Management in Patients With ECMO

NCT03832842 is registered in ClinicalTrials.gov with University Hospital, Strasbourg, France as lead sponsor.

NCT NCT03832842
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03832842 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thrombin Generation as a New Test for Anticoagulation Management in Patients With ECMO
Lead sponsor
University Hospital, Strasbourg, France
Phase
Observational
Overall status
Completed
Start date
May 16, 2019
Completion date
February 1, 2021
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

implantation of a veno-arterial or veno-venous ecmo